Urgent Safety Alert: New York-Based Fi Recalls Popular Dog Supplements Over Potential Salmonella Contamination

NEW YORK, NY — Pet owners nationwide are being urged to check their pantries and supplement cabinets following a voluntary recall issued by Fi, a prominent pet wellness company based in New York, NY. The company has announced the immediate recall of specific batches of its canine dietary supplements due to the potential presence of Salmonella.

The recall was triggered after the company discovered that a raw ingredient supplied to its third-party manufacturer may have been compromised. In response to the contamination risk, the manufacturer has temporarily suspended all production lines while an exhaustive investigation is conducted. Fi leadership emphasizes that the recall is being executed out of an abundance of caution, with direct notifications already deployed to all impacted customers.

The affected products were distributed broadly across the United States, reaching consumers directly through Fi’s official channels, as well as via major e-commerce platforms including Amazon and Chewy.com. Health officials are stressing the importance of immediate action for anyone who has purchased these specific batches, as Salmonella poses significant health risks to both animals and the humans who care for them.

Main Facts: What You Need to Know About the Fi Supplement Recall

The scope of the current recall is specific to two distinct canine supplement formulations produced by Fi. Consumers are urged to inspect their pet products immediately against the following list of recalled merchandise:

• Product Name: Fi Calming Supplement for Dogs (180 g)
  • Lot Number: 26118
  • UPC Code: 8 50064 80011 1
• Product Name: Fi 8-in-1 Formula Supplement for Dogs (180 g)
  • Lot Number: 26159
  • UPC Code: 8 50055 11168 4

The Nature of the Contamination

Salmonella is a pathogenic bacterium capable of causing severe gastrointestinal illness and other systemic complications in both humans and animals. According to regulatory filings, the contamination is traced back to a specific ingredient provided to Fi’s manufacturing partner. While no illnesses had been officially linked to the products at the time of the initial announcement, the tenacity of bacterial pathogens in dry goods necessitates a swift and comprehensive market withdrawal.

Immediate Action for Consumers

Pet owners who find they are in possession of the recalled lots are instructed to take the following steps:

1. Discontinue Use: Immediately stop administering the supplement to your dog.
2. Secure the Container: Ensure the product container is tightly sealed to prevent accidental exposure to children, pets, or household surfaces.
3. Dispose Safely: Discard the sealed container securely in the household trash. Do not compost the product or allow wildlife access to the discarded items.
4. Contact Support: Customers with lingering questions or concerns can reach Fi’s dedicated support team via phone at 1-888-434-3647 (available seven days a week, from 10:00 AM to 8:00 PM Eastern Time) or by electronic mail at [email protected].

Chronology of Events: From Ingredient Sourcing to Nationwide Recall

Understanding the timeline of a product recall provides valuable context regarding how supply chain vulnerabilities are identified and mitigated in the modern pet food industry.

Phase 1: Sourcing and Manufacturing Disruption

The roots of this safety alert trace back to the supply chain of Fi’s independent manufacturing partner. Fi utilizes specialized ingredients sourced from third-party vendors to create its functional canine supplements, such as calming aids and multi-benefit formulas. During routine quality assurance protocols or ingredient-level tracebacks, it was determined that a specific component used in the production cycle carried a risk of Salmonella exposure.

Phase 2: Internal Investigation and Production Halt

Upon discovering the potential compromise, the manufacturing facility took immediate corrective action. Production of the affected lines was halted entirely. This suspension allows quality control specialists, microbiologists, and supply chain auditors to trace the contaminated ingredient back to its origin, quarantine related inventory, and sanitize the manufacturing environment to prevent cross-contamination of other product lines.

Phase 3: Regulatory Coordination and Voluntary Withdrawal

Working in alignment with food safety standards and federal oversight, Fi formulated a voluntary recall strategy. Rather than waiting for reports of sickness to accumulate, company leadership chose a proactive path. Notifications were rapidly drafted for regulatory bodies, online retail partners like Amazon and Chewy, and individual retail customers who could be identified through direct-to-consumer purchase histories.

Phase 4: Public Notification and Outreach

The formal recall notice was published, detailing the exact lot numbers and UPC barcodes to ensure absolute clarity for pet owners. Fi’s customer service infrastructure was scaled up to handle inquiries, offering extended weekend and evening hours to assist concerned pet parents across multiple time zones.

Supporting Data: Understanding Salmonella Risks for Pets and Humans

Salmonella bacteria are notoriously resilient and can survive for extended periods in dry environments, making powdered or chewable pet supplements a potential vector for widespread transmission.

Risks to Human Health

Humans handling contaminated pet supplements, interacting with infected animals, or cleaning up pet waste are at a notable risk of contracting salmonellosis. This risk is exponentially higher if individuals fail to practice rigorous hygiene, such as thoroughly washing their hands with soap and water immediately after touching pet products, contaminated household surfaces, or animal feces.

Healthy adults infected with Salmonella typically experience an onset of symptoms within six hours to six days following exposure. Common indicators include:

• Nausea and vomiting
• Diarrhea, which can occasionally be bloody
• Severe abdominal cramping and pain
• Fever

In rare instances, Salmonella infections can lead to more severe, systemic medical complications. These include arterial infections, endocarditis (an infection of the heart valves), arthritis, muscle pain, eye irritation, and urinary tract symptoms. Individuals—particularly young children, the elderly, and immunocompromised persons—who develop these symptoms after handling the recalled Fi products are strongly advised to seek prompt medical attention from a healthcare provider.

Risks to Canine Health

Dogs afflicted with Salmonella may display a range of clinical signs, though some animals may appear completely asymptomatic while still shedding the bacteria. When symptoms do manifest, they commonly include:

• Lethargy and generalized weakness
• Diarrhea or bloody diarrhea
• Fever
• Vomiting
• Decreased or completely absent appetite
• Abdominal pain and discomfort

Crucially, pets that are infected but otherwise appear healthy can act as asymptomatic carriers. These animals can inadvertently transmit the bacteria to other household pets and human family members. Pet owners who observe any of the aforementioned symptoms in a dog that has consumed the recalled Fi supplements should contact their veterinarian immediately for diagnostic testing and supportive care.

Official Responses and Regulatory Guidance

Food and drug safety regulators emphasize that transparency and swift compliance are vital components of managing biological hazards in the consumer marketplace.

Federal Reporting Mechanisms

The U.S. Food and Drug Administration (FDA) monitors pet food and supplement safety through its Center for Veterinary Medicine (CVM). Pet owners or veterinarians who observe adverse reactions, unusual illnesses, or quality defects associated with these or any other pet products are encouraged to document the event.

Adverse events can be reported directly to the FDA via the online Form FDA 1932a, which is accessible through the agency’s official animal safety reporting portal at www.fda.gov/reportanimalae. This data assists federal regulators in tracking outbreak clusters, evaluating manufacturing compliance, and issuing broader public health advisories when necessary.

Retailer and Partner Cooperation

Major online distributors, including Amazon and Chewy.com, have cooperated with the recall execution. Automated purchase-history flags and direct messaging campaigns have been utilized where possible to alert customers who bought the items through third-party platform storefronts, ensuring that the recall notice reaches beyond Fi’s direct-to-consumer database.

Broader Implications: Supply Chain Integrity in the Pet Wellness Sector

The Fi supplement recall highlights broader systemic challenges facing the rapidly expanding pet wellness and supplement industry. As pet owners increasingly invest in preventative health, joint care, behavioral support, and dietary fortification for their companion animals, the volume of raw materials moving through specialized supply chains has skyrocketed.

The Vulnerability of Complex Supply Chains

Unlike traditional kibble manufacturing—which often undergoes high-temperature extrusion processes designed to kill common pathogens like Salmonella and E. coli—many modern supplements incorporate heat-sensitive vitamins, probiotics, botanicals, and palatability enhancers. These delicate ingredients are frequently blended post-processing or manufactured via cold-press techniques that may not eliminate bacterial contaminants if the raw inputs arrive pre-infected.

This structural reality places an immense burden of responsibility on ingredient sourcing departments. Vet-tech and pet supplement companies must maintain rigorous vendor-qualification programs, requiring rigorous third-party testing, certificates of analysis (COAs) for every incoming lot, and strict traceability protocols.

Consumer Confidence and Corporate Responsibility

Incidents like this serve as an ultimate test of corporate accountability. By halting production voluntarily, issuing transparent public notices, and providing clear remediation pathways for affected buyers, brands like Fi set a benchmark for crisis management. Nevertheless, every recall inevitably causes a temporary ripple of anxiety among consumers who rely on these products for their pets’ daily routines.

Industry analysts predict that this event will prompt heightened scrutiny from both regulators and consumer advocacy groups regarding the quality control standards applied to non-regulated or lightly regulated pet supplement categories. Moving forward, manufacturers within the pet wellness space are expected to accelerate investments in supply chain auditing, pathogen-reduction technologies, and internal laboratory testing capabilities to safeguard the human-animal bond.

Additional Resources and Reference Links

• Official FDA Recall Announcement: FDA Safety Alert – Fi Dog Supplements
• FDA Animal Adverse Event Reporting: Report Animal AE Portal
• Fi Customer Support: Call 1-888-434-3647 or email [email protected].